At a Glance
- Tasks: Lead late-stage R&D programmes for rare metabolic and genetic diseases.
- Company: Cycle Pharma, a pioneering firm in rare disease research based in Cambridge.
- Benefits: Hybrid work model, competitive salary, and opportunities for professional growth.
- Other info: Collaborative environment with a focus on innovation and mentorship.
- Why this job: Make a real difference in the lives of patients with rare diseases.
- Qualifications: Experience in R&D and regulatory strategy, leadership skills required.
The predicted salary is between 90000 - 110000 £ per year.
Cycle Pharma, headquartered in Cambridge, UK, is seeking a Director of Research & Development to own late-stage programmes focused on rare metabolic and genetic diseases. This is a hybrid role with a minimum of three days in the office, reporting to the Chief Strategy Officer, with end-to-end responsibility from strategy through regulatory submission and FDA interactions.
You will lead an integrated R&D function across Product Development, Clinical Operations and Regulatory Strategy, mentor teams, manage.
Director of Rare-Disease R&D & Regulatory Strategy (Hybrid) in Cambridge employer: Cycle Pharmaceuticals
Cycle Pharmaceuticals is an exceptional employer that prioritises meaningful work and employee growth, offering a collaborative and high-performing environment in the heart of Cambridge. With a strong commitment to diversity and inclusion, employees benefit from flexible hybrid working arrangements, comprehensive health insurance, and opportunities for professional development while contributing to life-changing treatments for patients. Join us to be part of a passionate team dedicated to making a real difference in the healthcare landscape.
